HUMAN TECHNOLOGIES INC (5621.T)
JPY 1360.0
(-0.44%)
JPY 1360.0
(-0.44%)
| Breakdown | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating Cash Flow | 398.07 Million | 257.01 Million | 263.92 Million |
| Net Income | 500.94 Million | 325.52 Million | 602.05 Million |
| Depreciation & Amortization | 31.91 Million | 32.15 Million | 19.32 Million |
| Deferred income taxes | - | - | - |
| Stock-based compensation | - | - | - |
| Change in working capital | -22.22 Million | 24.23 Million | -71.99 Million |
| Other non-cash items | 37.46 Million | 38.93 Million | -16.71 Million |
| Investing Cash Flow | -285.91 Million | -41.53 Million | -90.03 Million |
| Investments in PPE | -286.89 Million | -42.23 Million | -97.24 Million |
| Acquisitions | - | - | 832 Thousand |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | 982 Thousand | 701 Thousand | 6.37 Million |
| Financing Cash Flow | 1.35 Billion | -17.26 Million | -60.43 Million |
| Debt repayment | -224.51 Million | -111.42 Million | -60.43 Million |
| Dividends payments | -71.3 Million | -128.69 Million | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 1.66 Billion | - | - |
| Other Financing Activities | -14.14 Million | - | - |
| Accounts receivables | -99.79 Million | -74.99 Million | -72.04 Million |
| Accounts payables | 20.88 Million | 55.8 Million | 20.55 Million |
| Inventory | 1.72 Million | -6.69 Million | -5.08 Million |
| Other working capital | 62.39 Million | 88.11 Million | -15.05 Million |
| Cash at beginning of period | 1.84 Billion | 1.63 Billion | 1.51 Billion |
| Cash at end of period | 3.32 Billion | 1.84 Billion | 1.63 Billion |
| Capital Expenditure | -286.89 Million | -42.23 Million | -97.24 Million |
| Effect of forex changes on cash | 11.85 Million | 10.87 Million | 1.62 Million |
| Net cash flow / Change in cash | 1.48 Billion | 209.08 Million | 115.07 Million |
| Free Cash Flow | 111.18 Million | 214.77 Million | 166.68 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 210 Million | 112 Million | 500.94 Million | 91 Million | 66 Million | 66 Million |
| Depreciation & Amortization | - | - | 31.91 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -22.22 Million | - | - | - |
| Other non-cash items | -210 Million | -112 Million | 37.46 Million | -91 Million | -66 Million | -66 Million |
| Investing Cash Flow | - | - | -285.91 Million | - | - | - |
| Investments in PPE | - | - | -286.89 Million | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 982 Thousand | - | - | - |
| Financing Cash Flow | - | - | 1.35 Billion | - | - | - |
| Debt repayment | - | - | -224.51 Million | - | - | - |
| Dividends payments | - | - | -71.3 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1.66 Billion | - | - | - |
| Other Financing Activities | - | - | -14.14 Million | - | - | - |
| Accounts receivables | - | - | -99.79 Million | - | - | - |
| Accounts payables | - | - | 20.88 Million | - | - | - |
| Inventory | - | - | 1.72 Million | - | - | - |
| Other working capital | - | - | 62.39 Million | - | - | - |
| Cash at beginning of period | - | - | 1.84 Billion | - | - | - |
| Cash at end of period | - | - | 3.32 Billion | - | - | - |
| Capital Expenditure | - | - | -286.89 Million | - | - | - |
| Effect of forex changes on cash | - | - | 11.85 Million | - | - | - |
| Net cash flow / Change in cash | - | - | 1.48 Billion | - | - | - |
| Free Cash Flow | - | - | 111.18 Million | - | - | - |
ZMILGFIN
ICRA
SRSOLTD
ZYDUSWELL
0HR2
6139